BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dan DeNeui Named COO of BioTE Medical


1/25/2013 8:36:52 AM

DALLAS, Jan. 24, 2013 /PRNewswire/ -- BioTE Medical founder and President Dr. Gary Donovitz today announced the promotion of Dan DeNeui to COO. BioTE Medical is a Texas-based company that has played a significant role in the development of subcutaneous testosterone pellet therapy for men and women. DeNeui had been serving as the company's Vice President-Business Development.

(Photo: http://photos.prnewswire.com/prnh/20130124/LA48054)

Commenting on the promotion of DeNeui, Dr. Donovitz said, "Dan DeNeui has been such a critical part of our success at BioTE Medical. He was been instrumental in the launching of our company several years ago and is a major reason that BioTE is emerging as a national leader in the field of safe and effective testosterone replacement for men and women." According to Donovitz, DeNeui led an expansion of BioTE Medical to new markets. Donovitz added, "Because of Dan and our team, the BioTE Method of safe and effective testosterone pellet therapy is now being offered by leading medical professionals in a number of markets in the US. With the momentum that's been built, BioTE testosterone pellet therapy will be available coast to coast in the next year."

Dan DeNeui stated, "It's been a privilege to work with Dr. Donovitz, my staff and the medical practitioners who offer the BioTE Method. It's been very exciting to see our growth over the past 3 years. It is evident that BioTE is on the verge of some very exciting times ahead. We currently boast the largest patient population receiving the exact same Bio Identical Hormone Replacement Therapy in the US, and that number is growing exponentially each year. This obviously provides our company with some incredible opportunities."

In a marketplace that is becoming increasingly competitive with testosterone replacement creams, gels and shots, DeNeui said that the BioTE Method is being enthusiastically received by both consumers and physicians. DeNeui added, "There are numerous products on the market that simply don't work efficiently. And there are others, such as synthetic testosterone shots, that can present major issues for consumers. At BioTE Medical, we're driven by excellence. Bio-identical testosterone pellet therapy is by far the best method for both men and women to safely balance their hormones. And as trained medical professionals compare other modalities with BioTE Medical's testosterone pellets, we have become the best practices standard."

Dr. Donovitz praised the quality of physicians and medical practitioners who have joined team of professionals offering the BioTE Method. Donovitz stated, "We've been able to align ourselves with the best physicians and medical professionals in all of our markets. Compared to other clinics offering hormone replacement therapy, our physicians are clearly the most knowledgeable, best trained and most successful."

Both Donovitz and DeNeui cited BioTE Medical's physician training as a point of differentiation. DeNeui added, "When BioTE Medical partners with a doctor, we start with very complete training for not only the doctor but also their key employees. And it doesn't stop there. We're very committed to ongoing dialog and support. In fact, we have a division of the company that offers marketing support for our partners."

Regarding the growth of BioTE Medical, both Dr. Donovitz and DeNeui agree that the company is on the verge of significant growth. Dr. Donovitz added, "We're positioned well for major growth this year and beyond. Dan's done an exemplary job of building the infrastructure. The future is, indeed, very bright."

Interviews Available

Contact:
Pete Thomson
McQ Media
214-257-8484

SOURCE BioTE Medical



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES